Probiotics mitigate disruptions to gut microbiota during bacteria-eradication treatment – China RCT

By Hui Ling Dang

- Last updated on GMT

Probiotics supplementation could reduce gastrointestinal side effects and restore alterations to the gut microbiota caused by Helicobacter pylori-eradication therapy. ©Getty Images
Probiotics supplementation could reduce gastrointestinal side effects and restore alterations to the gut microbiota caused by Helicobacter pylori-eradication therapy. ©Getty Images

Related tags Probiotics Gut health gut microbiota

Probiotics supplementation could reduce gastrointestinal side effects and restore alterations to the gut microbiota caused by Helicobacter pylori (H. pylori)-eradication therapy, a new study reveals.

H. pylori​ is a bacterium in the stomach that is associated with several gastric diseases, including chronic gastritis, peptic ulcers and gastric cancer. The first line of treatment for H. pylori ​infection is typically a quadruple therapy comprising bismuth, a proton-pump inhibitor and two antibiotics.

Increasingly, H. pylori​-eradication drugs, especially antibiotics, are reported to cause short-term disruptions of the gut microbiota. According to previous studies, probiotics supplementation could mitigate these side effects.

To evaluate the impact of probiotics on gut microbiota after H. pylori​-eradication therapy, a double-blinded, randomised trial was performed at seven tertiary hospitals in China from March 2019 to November 2021.

Some 249 patients aged between 18 and 65 years, who were diagnosed chronic gastritis and tested positive for H. pylori​, were included in the study. The participants were randomly assigned to the probiotics group and the placebo group.

The probiotics group received a 14-day quadruple therapy (bismuth potassium citrate, esomeprazole, amoxicillin, furazolidone), combined with probiotics supplementation (Bifidobacterium tetravaccine tablets) for 28 days.

During the same period, the placebo group received the 14-day quadruple therapy alongside placebo (starch tablets).

Saliva, gastric mucosa and faecal samples were collected from all participants before and after therapy for analysis.
According to the findings, the incidence of gastrointestinal adverse events (GAE), such as vomiting, bloating and diarrhoea, was lower in the probiotics group than the placebo group (23.6% versus 37.7%), while there was no significant difference in H. pylori​-eradication rate.

Notably, patients supplemented with probiotics had smaller fluctuations of gut microbiota compared to those who received placebo. Furthermore, the microbiota was restored to baseline as soon as two weeks after the therapy.

“The reduction of gut Bacteroidetes caused by H. pylori-eradication drugs was neutralised by probiotics supplementation, indicating the ability of probiotics to maintain equilibrium of the gut microbiota ecosystem during exposure to antibiotics,” ​said the authors.

A need for multi-target probiotics

Approximately 50% of the population worldwide are H. pylori​-positive. Due to the growing prevalence of antibiotic resistance, the global recommendation for eradication treatment was changed from triple to quadruple therapy, with the duration prolonged from seven to 14 days. This has led to increased side effects and poor compliance.

Probiotics are commonly used to modulate gut microbiota and improve diseases like metabolic syndrome, colitis, and antibiotic-associated diarrhoea.

“In our study, changes in the composition of microbial community were not only observed in the gut, but also in the saliva and stomach. Our findings also indicated the reconstitution of gastric and oral microbiota after H. pylori-eradication by two weeks.

“This suggests that probiotics administration could influence microbiota along gastrointestinal tract in patients receiving eradication therapy. These results highlight a need to develop high-efficacy probiotics that target multiple parts of microbiota to improve resilience of the microbial ecosystem during disruptions, and to restore its equilibrium afterwards,” ​the authors concluded.


Source: Frontiers in Immunology​ 

“Probiotics modulate gastrointestinal microbiota after Helicobacter pylori eradication: A multicenter randomized double-blind placebo-controlled trial”

Authors: Cong He, et al

Related news

Show more

Related products

show more

Whitepaper: Discover a new era in postbiotics

Whitepaper: Discover a new era in postbiotics

Content provided by DSM Nutritional Products | 28-Nov-2023 | White Paper

Postbiotic ingredients are set to open up a world of opportunities across the human health and nutrition industry, fueled by developing science demonstrating...

Taking Immune Support to a New Level

Taking Immune Support to a New Level

Content provided by AB Biotek Human Nutrition & Health | 30-Oct-2023 | White Paper

Patent-pending ABB C1® redefines immune support by addressing innate, acquired, and Trained Immunity. In 'ABB C1®: Training Now for Future Immune...

Customize probiotics, optimize success

Customize probiotics, optimize success

Content provided by SYNBIO TECH INC. | 24-Jul-2023 | White Paper

As a product developer, all you want to do is to meet your customers' needs by customizing probiotic offering. However, probiotics are delicate live...

Full Vegan Protein Ingredients Solution

Full Vegan Protein Ingredients Solution

Content provided by Ingredients4u AG | 24-Jul-2023 | Product Brochure

Plant-based products have always been a hot topic in the market, the plant-based food market was valued at $29.4 billion in 2020.

Related suppliers

Follow us


View more


Nutra Champions Podcast

Nutra Champions Podcast